Nanoparticles: Is Neurotoxicity a Concern?

Nanotoxicity: From In Vivo and In Vitro Models to Health Risks

Volumn , Issue , 2009, Pages 171-182

  Wang, Jianyong ^a   Sun, Wenjun ^b   Ali, Syed F ^c  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Cardiovascular effects of particulate pollution; Nanoparticle and nanotube nanomaterials and foreseeable hazards; Nanoparticles and CNS access Inhalation route in atmospheric pollutants; Nanoparticles and neurotoxicity matter of concern; Nanoparticles and toxicological outcomes in organs; Nanoparticles on brain function and modifying BBB function; Nanoparticles with novel physico chemical properties and mechanisms of injury; Nanotechnology benefits and dangers to humanity and ecosystem; Oxidative stress and Alzheimer's disease; Polymers and ceramic nanoparticles in drug delivery systems

Indexed keywords

EID: 84890001611     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470747803.ch9     Document Type: Chapter

References (64)

1. Barnham KJ, Masters CL, Bush AI (2004) Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3, 205-214.
2. Beckett WS, Chalupa DF, Pauly-Brown A, Speers DM, Stewart JC, Frampton MW, Utell MJ, Huang LS, Cox C, Zareba W, Oberdörster G (2005) Comparing inhaled ultrafine versus fine zinc oxide particles in healthy adults: a human inhalation study. Am J Respir Crit Care Med 171, 1129-1135.
3. Block ML, Wu X, Pei Z, Li G, Wang T, Qin L, Wilson B, Yang J, Hong JS, Veronesi B (2004) Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase. FASEB J 18, 1618-1620.
4. Block ML, Hong JS (2007) Chronic microglial activation and progressive dopaminergic neurotoxicity. Biochem Soc Trans 35, 1127-1132.
5. Bosi S, Da Ros T, Spalluto G, Prato M (2003) Fullerene derivatives: an attractive tool for biological applications. Eur J Med Chem 38, 913-923.
6. Brown DM,Wilson MR,MacNee W, Stone V, Donaldson K (2001) Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 175, 191-199.
7. Calderón-Garcidueñas L, Azzarelli B, Acuna H, Garcia R, Gambling TM, Osnaya N, Monroy S, DEL Tizapantzi MR, Carson JL, Villarreal-Calderon A, Rewcastle B (2002) Air pollution and brain damage. Toxicol Pathol 30, 373-389.
8. Calderón-Garcidueñas L, Maronpot RR, Torres-Jardon R, Henríquez-Roldán C, Schoonhoven R, Acuña-Ayala H, Villarreal-Calderón A, Nakamura J, Fernando R, Reed W, Azzarelli B, Swenberg JA (2003) DNA damage in nasal and brain tissues of canines exposed to air pollutants is associated with evidence of chronic brain inflammation and neurodegeneration. Toxicol Pathol 31, 524-538.
9. Campbell A, Oldham M, Becaria A, Bondy SC, Meacher D, Sioutas C, Misra C, Mendez LB, Kleinman M (2005) Particulate matter in polluted air may increase biomarkers of inflammation in mouse brain. Neurotoxicology 26, 133-140.
10. Chen Z, Meng H, Xing G, Chen C, Zhao Y, Jia G, Wang T, Yuan H, Ye C, Zhao F, Chai Z, Zhu C, Fang X, Ma B, Wan L (2006) Acute toxicological effects of copper nanoparticles in vivo. Toxicol Lett 163, 109-120.
11. DonaldsonK,Aitken R, Tran L, Stone V, Duffin R, Forrest G, AlexanderA(2006) Carbon nanotubes:a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci 92, 5-22.
12. Donaldson K, Stone V, Tran CL, KreylingW, Borm PJ (2008) Nanotoxicology. Occup Environ Med 61, 727-728.
13. Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, Potter R,Maynard A, Ito Y, Finkelstein J, Oberdörster G (2006) Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 114, 1172-1178.
14. Fechter LD, Johnson DL, Lynch RA (2002) The relationship of particle size to olfactory nerve uptake of a non-soluble form of manganese into brain. Neurotoxicology 23, 177-183.
15. Feikert T, Mercer P, Corson N, Gelein R, Opanashuk L, Elder A, Silva V, Carter J, Maynard A, Finkelstein J, Oberdorster G. 2004. Inhaled solid ultrafine particles (UFP) are efficiently translocated via neuronal naso-olfactory pathways. Toxicologist 78(S1), 435-436.
16. Ferin J,Oberdörster G, Soderholm SC, Gelein R (1991) Pulmonary tissue access of ultrafine particles. J Aerosol Med 4, 57-68.
17. Ferin J, Oberdörster G (1992) Translocation of particles from pulmonary alveoli into the interstitium. J Aerosol Med 5, 179-187.
18. FischerHC, ChanWC(2007) Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol 18, 565-571.
19. Gianutsos G, Morrow GR, Morris JB (1997) Accumulation of manganese in rat brain following intranasal administration. Fundam Appl Toxicol 37, 102-105.
20. Hardman R (2006) A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect 114, 165-172.
21. Heckel K, Kiefmann R, Dorger M, Stoeckelhuber M, Goetz AE (2004) Colloidal gold particles as a new in vivo marker of early acute lung injury. Am J Physiol Lung Cell Mol Physiol 287, L867-L878.
22. Hussain SM, Javorina AK, Schrand AM, Duhart HM, Ali SF, Schlager JJ (2006) The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol Sci 92, 456-463.
23. Jani P, Halbert GW, Langridge J, Florence AT (1990) Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol 42, 821-826.
24. Kennedy P, Chaudhuri A (2002) Herpes simplex encephalitis. J Neurol Neurosurg Psychiatry 73, 237-238.
25. Kim S, Lim YT, Soltesz EG, De Grand AM, Lee J, Nakayama A, Parker JA, Mihaljevic T, Laurence RG, Dor DM, Cohn LH, Bawendi MG, Frangioni JV (2004) Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 22, 93-97.
26. KreylingWG, Semmler M, Erbe F, Mayer P, Takenaka S, SchulzH,Oberdörster G, ZiesenisA(2002) Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health 65A, 1513-1530.
27. Lee LJ (2006) Polymer nano-engineering for biomedical applications. Ann Biomed Eng 34, 75-88.
28. Lewinski N, Colvin V, Drezek R (2008) Cytotoxicity of nanoparticles. Small 4, 26-49.
29. Li N, Sioutas C, Cho A, Schmitz D, Misra C, Sempf J, Wang M, Oberley T, Froines J, Nel A (2003) Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect 111, 455-460.
30. Liao D, Creason J, Shy C, Williams R, Watts R, Zweidinger R (1999) Daily variation of particulate air pollution and poor cardiac autonomic control in the elderly. Environ Health Perspect 107, 521-525.
31. Lockman PR, Mumper RJ, Khan MA, Allen DD (2002) Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev Ind Pharm 28, 1-13.
32. Long TC, Tajuba J, Sama P, Saleh N, Swartz C, Parker J, Hester S, Lowry GV, Veronesi B (2007) Nanosize titanium dioxide stimulates reactive oxygen species in brain microglia and damages neurons in vitro. Environ Health Perspect 115, 1631-1637.
33. Maynard AD, Aitken RJ,Butz T,ColvinV,DonaldsonK,Oberdörster G, PhilbertMA, Ryan J, Seaton A, Stone V, Tinkle SS, Tran L, Walker NJ, Warheit DB (2006) Safe handling of nanotechnology. Nature 444, 267-269.
34. Medina C, Santos-Martinez MJ, Radomski A, Corrigan OI, Radomski MW (2007) Nanoparticles:pharmacological and toxicological significance. Br J Pharmacol 150, 552-558.
35. Meng H, Chen Z, Xing G, Yuan H, Chen C, Zhao F, Zhang C, Zhao Y (2007) Ultrahigh reactivity provokes nanotoxicity: explanation of oral toxicity of nano-copper particles. Toxicol Lett 175, 102-110.
36. Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM (2008) Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci 101, 239-253.
37. Nel A (2005) Atmosphere. Air pollution-related illness: effects of particles. Science 308, 804-806.
38. Nel A, Xia T, Mädler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311, 622-627.
39. Nemmar A, Hoylaerts MF, Hoet PH, Nemery B (2004) Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects. Toxicol Lett 149, 243-253.
40. Oberdörster E (2004) Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environ Health Perspect 112, 1058-1062.
41. Oberdörster G (2000) Toxicology of ultrafine particles: in vivo studies. Philos Trans R Soc Lond A 358, 2719-2740.
42. Oberdörster G, Ferin J,GeleinR, Soderholm SC, Finkelstein J (1992) Role of the alveolar macrophage in lung injury: studies with ultrafine particles. Environ Health Perspect 97, 193-197.
43. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, Kreyling W, Cox C (2002) Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health 65A, 1531-1543.
44. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, KreylingW, Cox C (2004) Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16, 437-445.
45. Oberdörster G, Oberdörster E, Oberdörster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113, 823-839.
46. Plattig K-H (1989) Electrophysiology of taste and smell. Clin Phys Physiol Meas 10, 91-126.
47. Rahman MF, Wang J, Patterson TA, Saini UT, Robinson BL, Duhart HM, Newport GD, Murdock RC, Schlager JJ, Hussain SM, Ali SF (2009) Expression of gene related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol Lett 187, 15-21.
48. Rodoslav S, Laibin L, Eisenberg A, Dusica M (2003) Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 300, 615-618.
49. Sarker DK (2005) Engineering of nanoemulsions for drug delivery. Curr Drug Deliv 2, 297-310.
50. Seaton A, MacNee W, Donaldson K, Godden D (1995) Particulate air-pollution and acute healtheffects. Lancet 345, 176-178.
51. Seaton A, Donaldson K (2005) Nanoscience, nanotoxicology, and the need to think small. Lancet 365, 923-924.
52. Sharma HS (2007) Nanoneuroscience: emerging concepts on nanoneurotoxicity and nanoneuroprotection. Nanomed 2, 753-758.
53. Sharma HS, Westman J (2004) The Blood-Spinal Cord and Brain Barriers in Health and Disease. Elsevier Academic Press: San Diego, CA.
54. Sharma HS, Sharma A (2007) Nanoparticles aggravate heat stress induced cognitive deficits, bloodbrain barrier disruption, edema formation and brain pathology. Prog Brain Res 162, 245-273.
55. Stern ST, McNeil SE (2008) Nanotechnology safety concerns revisited. Toxicol Sci 101, 4-21.
56. Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, Schramel P, Heyder J (2001) Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect 109, 547-551.
57. Tang M, Xing T, Zeng J, Wang H, Li C, Yin S, Yan D, Deng H, Liu J, Wang M, Chen J, Ruan DY (2008) Unmodified CdSe quantum dots induce elevation of cytoplasmic calcium levels and impairment of functional properties of sodium channels in rat primary cultured hippocampal neurons. Environ Health Perspect 116, 915-922.
58. Tinkle SS, Antonini JM, Rich BA, Roberts JR, Salmen R, DePree K, Adkins EJ (2003) Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect 111, 1202-1208.
59. Veronesi B, Makwana O, Pooler M, Chen LC (2005) Effects of subchronic exposures to concentrated ambient particles. VII. Degeneration of dopaminergic neurons in Apo E-/-mice. Inhal Toxicol 17, 235-241.
60. Wang J, Rahman MF, Duhart HM, Newport GD, Patterson TA, Murdock RC, Hussain SM, Schlager JJ, Ali SF (2008) Expression changes of dopaminergic system-related genes in PC12 cells induced by manganese, silver, or copper nanoparticles. Toxicologist 102(S1), 214.
61. Warheit DB (2008) How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? Toxicol Sci 101, 183-185.
62. Weng J, Ren J (2006) Luminescent quantum dots: a very attractive and promising tool in biomedicine. Curr Med Chem 13, 897-909.
63. Xia T, Li N, Nel AE (2009) Potential health impact of nanoparticles. Annu Rev Public Health 30, 130-150.
64. Yamago S, Tokuyama H, Nakamura E, Kikuchi K, Kananishi S, Sueki K, Nakahara H, Enomoto S, Ambe F (1995) In vivo biological behavior of a watermiscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity. Chem Biol 2, 385-389.